News - Pharmaceutical
NGO scaremonger? Or pharmaceutical flunky?
10 January 2013
Trade can be an engine for development if its benefits reach those living in poverty. Oxfam has argued for this for more than a decade. Philip Stevens of the Emerging Markets Health Network, in a Wall Street Journal Asia op-ed at the end of last year ...
Click on the link to read the full article at Oxfam America (This link will open in a new window)Pharmaceutical industry would grow at 19% in 2013: Morgan Stanley
10 January 2013
Based on this, the company has given Overweight ( Buy ) and Equalweight (Hold) ratings to the large pharmaceutical stocks. According to the report, long term strategies appear better for Sun Pharma, Lupin and Dr Reddy's Lab. Cipla and Ranbaxy will need ...
Click on the link to read the full article at Economic Times (This link will open in a new window)Pharmaceutical industry opposes MFN status for India
9 January 2013
ISLAMABAD - Pharmaceutical Manufacturers' Association of Pakistan (PPMA) expressed grave concern over the government's seeming insistence on granting MFN status to India without taking into account the valid concerns of the domestic pharmaceutical ...
Click on the link to read the full article at PakistanToday.com.pk (This link will open in a new window)Pharmaceutical Firm Settles Lawsuit Over Pregnancy Drug
9 January 2013
BOSTON (AP) - A lawyer for four sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s says they have reached a settlement with a pharmaceutical company. Attorney Julie Oliver-Zhang says the deal ...
Click on the link to read the full article at KRIS Corpus Christi News (This link will open in a new window)Percentage of Pharmaceutical Companies Outsourcing Regulatory Affairs ...
9 January 2013
A majority of surveyed pharmaceutical companies outsource at least part of their regulatory affairs budget. This is up 5% from 2010, demonstrating that fewer drug companies are trying to keep such activities entirely in-house than before, according to ...
Click on the link to read the full article at PharmiWeb.com (press release) (This link will open in a new window)The Daily Docket: KV Pharmaceutical Unveils Bankruptcy Plan
9 January 2013
K-V Pharmaceutical Co. Monday unveiled a bankruptcy-exit plan that hinges on a $20 million rights offering and has already earned the support of a group of senior noteholders. Read the Daily Bankruptcy Review article here. (Daily Bankruptcy Review and ...
Click on the link to read the full article at Wall Street Journal (blog) (This link will open in a new window)LCQ12: Regulation of pharmacists and the pharmaceutical trade
9 January 2013
At present, the Pharmacy and Poisons Board of Hong Kong (the Board) is responsible for matters relating tothe regulation of pharmacists and the pharmaceutical industry. Some pharmacists have relayed to me that as the Board is responsible only for the ...
Click on the link to read the full article at 7thSpace Interactive (press release) (This link will open in a new window)Successful Pharmaceutical Commercialization Efforts Center on a Compound ...
9 January 2013
To gain a foothold in today?
Click on the link to read the full article at PharmiWeb.com (press release) (This link will open in a new window)OCTOPLUS : announces agreement with leading pharmaceutical company for
9 January 2013
OCTOPLUS ANNOUNCES AGREEMENT WITH LEADING PHARMACEUTICAL COMPANY FOR DEVELOPMENT OF A CONTROLLED RELEASE FORMULATION Leiden, the Netherlands, 11 January 2012 - OctoPlus N.V. ("OctoPlus" or the "Company") ...
Click on the link to read the full article at 4-traders (This link will open in a new window)Indonesia's pharmaceutical industry estimates slight decline in growth
9 January 2013
The growth of Indonesia's pharmaceutical industry in 2013 is projected to be not as strong as in last year due to expected rise in production cost, an industry leader said here Wednesday. The rising in electricity tariff and labor's minimum wage will ...
Click on the link to read the full article at Global Times (This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
